Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016

from Listen to The Lancet Neurology · host The Lancet

Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.

Episode metadata supplied by the publisher feed · Published Jun 7, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016

0:00 11:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Neurology?

This episode is 11 minutes long.

When was this Listen to The Lancet Neurology episode published?

This episode was published on June 7, 2016.

Can I download this Listen to The Lancet Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!